BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for Seraclone Anti-S, Biorad

Product group In-vitro diagnostics - haematological, histological and cytological products
Reference 04384/13

Corrective action from Biorad for Seraclone Anti-S due to a reactivity decrease. Customers were informed accordingly.

Corrective action for Seraclone Anti-S, Biorad , Download_VeroeffentlichtAm_EN PDF, 79KB, File does not meet accessibility standards